Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

• Status: Completed
• Trial end date: 2007-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Rivastigmine is effective for the prevention of postoperative delirium in patients undergoing cardiac surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Basel, Switzerland
• Collaborator: Novartis
• Treatments: Rivastigmine

Criteria

Inclusion Criteria:

• Patients undergoing cardiac surgery with use of extracorporeal circulation

• Aged 65 or more

Exclusion Criteria:

• "redo" procedures

• anticipated use of succinylcholine during operation

• contraindications to rivastigmine

• preoperative mini mental score < 15